Nasdaq · CIK 0001858685
BFRI Biofrontera Inc.
Insider trading from SEC Form 4. Last filing Jul 29, 2026.
In brief
Biofrontera Inc. (BFRI) has 17 SEC Form 4 filings on file from 8 insiders, the latest filed on Jul 29, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
Last 90 days
Signals
Open-market buys and sells at Biofrontera Inc., scored.
Transactions
Every row filed, 32 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 28, 2026 | Hermann Luebbert CEO & Chairman | MOption exercise Common Stock | +62,500 | - | - | 352,711 | Jul 29, 2026 |
| Jul 28, 2026 | Eugene Frederick Leffler Chief Financial Officer | MOption exercise Common Stock | +31,250 | - | - | 206,250 | Jul 29, 2026 |
| Jul 28, 2026 | Eugene Frederick Leffler Chief Financial Officer | MOption exercise Restricted Stock Unitsderivative | -31,250 | $0.00 | $0 | 31,250 | Jul 29, 2026 |
| Jul 28, 2026 | Hermann Luebbert CEO & Chairman | MOption exercise Restricted Stock Unitsderivative | -62,500 | $0.00 | $0 | 62,500 | Jul 29, 2026 |
| Mar 5, 2026 | Eugene Frederick Leffler Chief Financial Officer | MOption exercise Common Stock | +87,500 | - | - | 175,000 | Mar 6, 2026 |
| Mar 4, 2026 | Kevin Daniel Weber director | AGrant or award Employee stock option (right to buy)derivative | +20,000 | $0.00 | $0 | 20,000 | Mar 6, 2026 |
| Mar 5, 2026 | Hermann Luebbert CEO & Chairman | MOption exercise Common Stock | +137,500 | - | - | 290,211 | Mar 6, 2026 |
| Mar 4, 2026 | John J Borer III director | AGrant or award Employee stock option (right to buy)derivative | +20,000 | $0.00 | $0 | 20,000 | Mar 6, 2026 |
| Mar 4, 2026 | George Patrick Jones Chief Commercial Officer | AGrant or award Restricted Stock Unitsderivative | +50,000 | $0.00 | $0 | 50,000 | Mar 6, 2026 |
| Mar 4, 2026 | Beth J. Hoffman director | AGrant or award Employee stock option (right to buy)derivative | +20,000 | $0.00 | $0 | 20,000 | Mar 6, 2026 |
| Mar 4, 2026 | Heikki Lanckriet director | AGrant or award Employee stock option (right to buy)derivative | +20,000 | $0.00 | $0 | 20,000 | Mar 6, 2026 |
| Mar 4, 2026 | George Patrick Jones Chief Commercial Officer | AGrant or award Employee stock option (right to buy)derivative | +50,000 | $0.00 | $0 | 50,000 | Mar 6, 2026 |
| Mar 4, 2026 | Eugene Frederick Leffler Chief Financial Officer | AGrant or award Restricted Stock Unitsderivative | +62,500 | $0.00 | $0 | 62,500 | Mar 6, 2026 |
| Mar 4, 2026 | Hermann Luebbert CEO & Chairman | AGrant or award Restricted Stock Unitsderivative | +125,000 | $0.00 | $0 | 125,000 | Mar 6, 2026 |
| Mar 4, 2026 | Hermann Luebbert CEO & Chairman | AGrant or award Employee stock option (right to buy)derivative | +125,000 | $0.00 | $0 | 125,000 | Mar 6, 2026 |
| Mar 4, 2026 | Eugene Frederick Leffler Chief Financial Officer | AGrant or award Employee stock option (right to buy)derivative | +62,500 | $0.00 | $0 | 62,500 | Mar 6, 2026 |
| Mar 5, 2026 | Hermann Luebbert CEO & Chairman | MOption exercise Restricted Stock Unitsderivative | -137,500 | $0.00 | $0 | 0 | Mar 6, 2026 |
| Mar 5, 2026 | Eugene Frederick Leffler Chief Financial Officer | MOption exercise Restricted Stock Unitsderivative | -87,500 | $0.00 | $0 | 0 | Mar 6, 2026 |
| Sep 16, 2025 | Biofrontera AG director, owner | POpen-market purchase Series D Convertible Preferred Stockderivative | +3,019 | - | - | 3,019 | Sep 18, 2025 |
| Jul 22, 2025 | Kevin Daniel Weber director | AGrant or award Employee stock option (right to buy)derivative | +20,000 | $0.00 | $0 | 20,000 | Sep 16, 2025 |
| Jul 22, 2025 | Heikki Lanckriet director | AGrant or award Employee stock option (right to buy)derivative | +20,000 | $0.00 | $0 | 20,000 | Sep 16, 2025 |
| Jul 22, 2025 | Beth J. Hoffman director | AGrant or award Employee stock option (right to buy)derivative | +20,000 | $0.00 | $0 | 20,000 | Sep 16, 2025 |
| Jul 22, 2025 | John J Borer III director | AGrant or award Employee stock option (right to buy)derivative | +20,000 | $0.00 | $0 | 20,000 | Sep 16, 2025 |
| Sep 10, 2025 | Hermann Luebbert CEO & Chairman | MOption exercise Common Stock | +137,500 | - | - | 152,711 | Sep 16, 2025 |
| Sep 10, 2025 | Eugene Frederick Leffler Chief Financial Officer | MOption exercise Common Stock | +87,500 | - | - | 87,500 | Sep 16, 2025 |
| Sep 15, 2025 | George Patrick Jones Chief Commercial Officer | AGrant or award Employee stock option (right to buy)derivative | +100,000 | $0.00 | $0 | 100,000 | Sep 16, 2025 |
| Jul 22, 2025 | Eugene Frederick Leffler Chief Financial Officer | AGrant or award Restricted Stock Unitsderivative | +62,500 | $0.00 | $0 | 62,500 | Sep 16, 2025 |
| Jul 22, 2025 | Hermann Luebbert CEO & Chairman | AGrant or award Restricted Stock Unitsderivative | +125,000 | $0.00 | $0 | 125,000 | Sep 16, 2025 |
| Jul 22, 2025 | Eugene Frederick Leffler Chief Financial Officer | AGrant or award Employee stock option (right to buy)derivative | +62,500 | $0.00 | $0 | 62,500 | Sep 16, 2025 |
| Jul 22, 2025 | Hermann Luebbert CEO & Chairman | AGrant or award Employee stock option (right to buy)derivative | +125,000 | $0.00 | $0 | 125,000 | Sep 16, 2025 |
| Sep 10, 2025 | Hermann Luebbert CEO & Chairman | MOption exercise Restricted Stock Unitsderivative | -137,500 | $0.00 | $0 | 137,500 | Sep 16, 2025 |
| Sep 10, 2025 | Eugene Frederick Leffler Chief Financial Officer | MOption exercise Restricted Stock Unitsderivative | -87,500 | $0.00 | $0 | 87,500 | Sep 16, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- John J Borer IIIdirector
- Biofrontera AGdirector, owner
- Beth J. Hoffmandirector
- George Patrick JonesChief Commercial Officer
- Heikki Lanckrietdirector
- Eugene Frederick LefflerChief Financial Officer
- Hermann LuebbertCEO & Chairman
- Kevin Daniel Weberdirector
Questions about BFRI
Answered from the filings on this page, as of the latest one.
Are insiders buying BFRI?
No. In the last 90 days no insider at Biofrontera Inc. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade BFRI on the open market?
No open-market trade has been scored at Biofrontera Inc.. The latest Form 4 on file was filed on Jul 29, 2026 and holds grants, exercises or other rows that are not market trades.
How many insiders file Form 4 at Biofrontera Inc.?
8 people have filed a Form 4 at Biofrontera Inc., among them John J Borer III (director), Biofrontera AG (director and 10% owner), Beth J. Hoffman (director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.